Vera Therapeutics, Inc. (VERA) Social Stream
Vera Therapeutics Inc (VERA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering VERA.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
VERA's average price target has moved up $5.67 over the prior 28 weeks.
VERA reports an average of 46.43% for its upside potential over the past 41 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
VERA Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how Vera Therapeutics Inc fares relative to all US stocks, note that its number of analysts covering the stock is higher than 60.44% of that group.
- In terms of how Vera Therapeutics Inc fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 56.15% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Vera Therapeutics Inc's variance in analysts' estimates is lower than -4.55% of them.
- In the context of stocks in the small market cap category, Vera Therapeutics Inc's average analyst price target is higher than 265.68% of them.
In the Pharmaceutical Products industry, VBIV, VAXX, and VACC are the three stocks most similar to Vera Therapeutics Inc regarding the price target and analyst recommendation information presented here.
Is VERA a Buy, Hold or Sell? See the POWR Ratings now!